ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · IEX Real-Time Price · USD

9.71

+0.19 (2.00%)

At close: May 3, 2024, 4:00 PM

10.01

+0.30 (3.09%)

After-hours: May 3, 2024, 5:30 PM EDT

ORIC Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	655	502	233	579	1,170
Market Cap Growth	-	115.30%	-59.73%	-50.50%	-
Enterprise Value	446	294	27	342	876
PE Ratio	-4.98	-4.98	-2.62	-7.35	-15.87
PB Ratio	2.92	2.24	1.05	2.12	4.04
P/FCF Ratio	-5.80	-5.80	-3.02	-9.57	-25.46
P/OCF Ratio	-5.86	-5.86	-3.10	-9.72	-25.84
EV/EBITDA Ratio	-2.95	-2.95	-0.30	-4.39	-12.04
EV/EBIT Ratio	-2.92	-2.92	-0.30	-4.34	-11.89
EV/FCF Ratio	-3.39	-3.39	-0.35	-5.65	-19.07
Quick Ratio	10.18	10.18	13.40	15.64	32.61
Current Ratio	10.39	10.39	13.68	15.88	32.96
Return on Equity (ROE)	-42.70%	-42.70%	-38.50%	-28.70%	-51.60%
Return on Assets (ROA)	-38.60%	-38.60%	-35.00%	-27.00%	-37.90%
Return on Capital (ROIC)	-49.44%	-49.44%	-41.27%	-28.89%	-25.60%
Earnings Yield	-15.38%	-20.06%	-38.23%	-13.60%	-6.30%
FCF Yield	-13.22%	-17.24%	-33.13%	-10.45%	-3.93%
Buyback Yield / Dilution	-29.75%	-29.75%	-4.48%	-72.97%	-1055.26%
Total Shareholder Return	-29.75%	-29.75%	-4.48%	-72.97%	-1055.26%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).